Robert Kramer

2019 - Emergent BioSolutions

In 2019, Robert Kramer earned a total compensation of $3.7M as President and Chief Executive Officer at Emergent BioSolutions, a 54% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$557,108
Option Awards$1,012,999
Salary$678,021
Stock Awards$1,439,958
Other$5,735
Total$3,693,821

Kramer received $1.4M in stock awards, accounting for 39% of the total pay in 2019.

Kramer also received $557.1K in non-equity incentive plan, $1M in option awards, $678K in salary and $5.7K in other compensation.

Rankings

In 2019, Robert Kramer's compensation ranked 3,272nd out of 13,971 executives tracked by ExecPay. In other words, Kramer earned more than 76.6% of executives.

ClassificationRankingPercentile
All
3,272
out of 13,971
77th
Division
Manufacturing
1,181
out of 5,701
79th
Major group
Chemicals And Allied Products
402
out of 2,200
82nd
Industry group
Drugs
331
out of 1,886
82nd
Industry
Pharmaceutical Preparations
247
out of 1,398
82nd
Source: SEC filing on April 9, 2021.

Kramer's colleagues

We found six more compensation records of executives who worked with Robert Kramer at Emergent BioSolutions in 2019.

2019

Robert Kramer

Emergent BioSolutions

Chief Executive Officer

2019

Fuad El-Hibri

Emergent BioSolutions

Chairman

2019

Richard Lindahl

Emergent BioSolutions

Chief Financial Officer

2019

Atul Saran

Emergent BioSolutions

General Counsel

2019

Adam Havey

Emergent BioSolutions

Executive Vice President, Business Operations

2019

Daniel Abdun-Nabi

Emergent BioSolutions

Chief Executive Officer

News

You may also like